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Abstract
Background: Significant long-term reduction in health-related quality of life (HRQoL) is often observed in survivors
of the acute respiratory distress syndrome (ARDS), and return to work (RtW) is limited. There is a paucity of data
regarding the relationship between the quality of care (QoC) in the intensive care unit (ICU) and both HRQoL and
RtW in ARDS survivors. Therefore, the aim of our study was to investigate associations between indicators of QoC
and HRQoL and RtW in a cohort of survivors of ARDS.
Methods: To determine the influence of QoC on HRQoL and RtW 1 year after ICU-discharge, ARDS patients were
recruited into a prospective multi-centre patient cohort study and followed up regularly after discharge. Patients
were asked to complete self-report questionnaires on HRQoL (Short Form 12 physical component scale (PCS) and
mental component scale (MCS)) and RtW. Indicators of QoC pertaining to volume, structural and process quality,
and general characteristics were recorded on ICU level. Associations between QoC indicators and HrQoL and RtW
were investigated by multivariable linear and Cox regression modelling, respectively. B values and hazard ratios
(HRs) are reported with corresponding 95% confidence intervals (CIs).
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Results: 877 (of initially 1225 enrolled) people with ARDS formed the DACAPO survivor cohort, 396 were finally
followed up to 1 year after discharge. The twelve-month survivors were characterized by a reduced HRQoL with a
greater impairment in the physical component (Md 41.2 IQR [34–52]) compared to the mental component (Md 47.3
IQR [33–57]). Overall, 50% of the patients returned to work. The proportion of ventilated ICU patients showed
significant negative associations with both 12 months PCS (B = − 11.22, CI −20.71; − 1,74) and RtW (HR = 0,18, CI 0,
04;0,80). All other QoC indicators were not significantly related to outcome.
Conclusions: Associations between ICU QoC and long-term HrQoL and RtW were weak and largely non-significant.
Residual confounding by case mix, treatment variables before or during ICU stay and variables pertaining to the
post intensive care period (e.g. rehabilitation) cannot be ruled out.
Trial registration: Clinicaltrials.govNCT02637011.
(December 22, 2015, retrospectively registered)
Keywords: ARDS, Quality of care, Volume, ICU, Health-related quality of life, Return to work
Background
Acute respiratory syndrome (ARDS) is characterised by re-
spiratory failure with either a direct pulmonary (e.g. pneu-
monia) or extra-pulmonary cause (e.g. sepsis) that requires
treatment in intensive care including mechanical ventilation
[1]. Approximately 10% of all patients admitted to the ICU
develop ARDS [2]. This represents a considerable amount
of patients. Further, cost associated with ARDS are very
high. For instance, a study from the UK estimated mean so-
cietal cost over 1 year including initial ICU treatment cost
at £ 44.077 [3]. A US study estimated the median cost due
to hospitalization post-discharge at $ 18.756 [4].
With mortality estimated up to 45%, the focus of
ARDS research has been on mortality for a long time.
With decreasing mortality rates [5] however, the interest
in long-term outcomes such as mental health, return to
work (RtW) and health-related quality of life (HRQoL)
of ARDS patients increased [6–10].
A multi-centre national study in the U.S. showed that
nearly half of previously employed ARDS survivors were
jobless at 12months after ARDS and that this was accom-
panied by substantial lost earnings [11]. If one aims at im-
proving long-term outcome for these patients, it is
important to shed light on possible determinants of out-
comes such as HRQoL and RtW. We performed a system-
atic literature review [12] summarising the existing
evidence regarding the determinants of HRQoL or RtW in
ARDS patients, including 24 highly heterogeneous observa-
tional studies. One of the main findings was that the core
focus of published research was on clinical and care-related
determinants (performance in pulmonary function testing,
duration of ICU treatment etc.) which mainly showed
small, non-significant effects on HRQoL and RtW. Despite
the evident role of the care provided to patients with ARDS
in the ICU, surprisingly, the role of quality of care (QoC)
for long-term HRQoL and RtW has not been investigated
thus far while ARDS mortality has been investigated in rela-
tion to university level of care [13].
Against this background, the hypothesis underlying
the study presented in this paper was that better QoC
(defined by quality indicators) received during the acute
ICU stay was associated with better HRQoL and a higher
rate of RtW in survivors of ARDS. Thus, our aim was to
identify QoC indicators predictive of HRQoL and RtW.
Methods
Study design and sample
Methods of the DACAPO (Surviving ARDS: the influence
of quality of care and individual patient characteristics on
health-related quality of life) study have been described in
detail elsewhere [14, 15]. Briefly, adult patients with diag-
nosed ARDS according to the Berlin definition [16] were
recruited in 61 intensive care units (ICUs) across
Germany into a cohort study with three postal follow-ups
(3, 6 and 12 months). Ethical approval was obtained from
the ethics committee of the University of Regensburg (file
number: 13–101-0262) and additionally from the ethics
committees overseeing the respective study sites.
Measurements
Outcomes
The Short Form-12 self-report questionnaire (SF-12)
was used to measure HRQoL [17]. Scores for the Phys-
ical Component (PCS-12) and the Mental Component
Scales (MCS-12) range from 0 to 100 (higher values in-
dicating better HRQoL). Fifty is the mean value for the
general population (German norm values [18]). RtW was
captured as self-report, asking whether and when people
had returned to their previous or another job (only for
persons in employment before admission to ICU). We
included data from all participants who returned valid
questionnaires up to 13 months after discharge from
ICU. Mortality status and date of death were assessed ei-
ther through reports from the patients’ caregivers or
through local population registries.
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Exposures
QoC was assessed at the level of the participating ICUs
once during the period of the study. It was operational-
ized as structural quality (head of the ICU with add-
itional training in intensive care medicine), process
quality (implementation of daily multi-professional ward
rounds with documentation of daily therapy goals), volume
(number of ventilated patients per year), and general char-
acteristics (membership of the hospital in the ARDS Net-
work Germany). These pre-specified indicators showed
limited statistical variance and were thus complemented by
additional quality indicators comprising the proportion of
physicians with completed specialized ICU training, the
availability of weekly microbiological ward rounds, the
proportion of ventilated patients on all patients, and gen-
eral level of care (university hospital versus other hospital).
Both the pre-specified and the additional quality indica-
tors were largely based on the published list of German
quality indicators in intensive care medicine [14, 19, 20]
and together with generally accepted indicators such as
volume and level of care have been used in the compre-
hensive QoC assessment in the DACAPO study.
Potentially confounding variables
Variables related to socio-demographic, clinical and care
aspects were assessed as potentially confounding vari-
ables. The socio-demographic variables included age,
sex, living situation (living with versus without a part-
ner), nationality (German, other), and health insurance
(statutory, private, other). An education score was de-
rived from information on the participants’ educational
and professional levels (according to Lampert et al. [21]).
The score ranges between 1 and 7, with higher values in-
dicating higher educational and/or professional achieve-
ments. General medical characteristics were captured
with regard to body mass index (BMI: kg/m2), cause of
ARDS (pulmonary / extra-pulmonary), Simplified Acute
Physiology Score II (SAPS-II) [22], and Sequential Organ
Failure Assessment (SOFA) [23] score, as well as self-
reported physician-diagnosed mental disorder before
treatment in the ICU (any, none). The Berlin definition
of ARDS was modified in terms of the classification of
the severity of hypoxemia (PaO2/FIO2 ratio [P/F ratio])
since the classification into two levels (P/F ratio ≤ 150
mmHg versus > 150 mmHg) may allow better selectivity
between mild and severe cases [24, 25].
Statistical analysis
Owing to the data structure (patients are nested within
different ICUs), we used hierarchical linear modeling,
testing whether there was systematic variance between
the second-level units (ICUs) in the primary outcome at
the three follow-ups. For all outcomes, these analyses
yielded an intraclass correlation coefficient (ICC)
consistently close to zero on the basis of the fully uncon-
ditional model and non-significant p-values for the like-
lihood ratio tests indicating non-deterioration in model
fit if the random intercept was restricted to zero (data
not shown). For this reason, fixed-effects linear, logistic
and Cox regression models were applied.
Outcome: health-related quality of life (HRQoL)
The twelve-month analysis was the primary analysis. For
each follow-up (3, 6 and 12 months) and each expos-
ure–outcome combination non-adjusted, minimally ad-
justed, and fully adjusted linear regression models were
used. The minimally adjusted model contained sex, age,
and ARDS severity as covariates; all socio-demographic
and medical variables which were significantly (p-value
< 0.05) associated with exposures or outcome at any
follow-up period were included in the fully adjusted re-
gression models. Non-standardized regression coeffi-
cients with 95% confidence intervals (CIs) were
computed as were standardized regression coefficients.
Outcome: return to work (RtW)
We used Cox proportional hazards models to analyse
RtW. The minimally adjusted models had sex, age, and
ARDS-severity as covariates. The fully adjusted multivari-
ate Cox models included all covariates that showed signifi-
cant effects with either outcome or exposure in univariate
Cox regression analyses. Observations were censored if
RtW did not occur within 395 days following ICU dis-
charge. Hazard ratios (HRs) with 95% CIs were computed.
Outcome: mortality
We examined the influence of the exposure variables on 1-
year mortality in ICU survivors. The set of covariates for
the fully adjusted logistic regression models was determined
as described for HRQoL and RtW. Odds ratios (ORs) and
95% CIs were computed. A p-value of < 0.05 was consid-
ered statistically significant. Analyses were performed using
Stata 13.1 (Stata Corporation, College Station, TX, U.S.A.).
Results
Descriptive results
We preliminarily included 1900 ARDS patients from 61
ICUs across Germany between September 2014 and
April 2016. One thousand two hundred twenty five pa-
tients with informed consent formed the initial ICU
sample (Fig. 1). Eight hundred seventy-seven patients
formed the DACAPO survivor cohort. Four hundred
eighty-one patients (54.8%) were lost to follow up for
various reasons (e.g.inability to participate). Information
on death or survival could not be obtained for 66 pa-
tients. At 1 year after discharge, 19.8% had died and 396
persons were followed up.
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The socio-demographic and general medical charac-
teristics of the respondents for the twelve-month
follow-up are described in an additional file (Table 4,
additional file 1). In about 60% the diagnosis was
made in a DACAPO ICU, the remainder was trans-
ferred. The ARDS was predominantly caused by direct
(pulmonary) conditions. The majority of patients
(75%) suffered from ‘moderate-to-severe’ ARDS (P/F
ratio < 150). A lifetime diagnosis of a mental disorder
was reported in 15%.
The general characteristics and the organizational and
structural QoC indicators of the participating ICUs were
as follows (Table 1): 70% of study centres were members
of the German ARDS network and 28 centres were
university institutions. The median number of patients
ventilated per year was 493 and the median percent
of patients who were ventilated was 44%. The twelve-
month ARDS survivors reported a median physical
SF-12 (SF-12 PCS) of 41 (IQR 35–52) and a mental
SF-12 (SF-12 MCS) of 47 (IQR 33–57) Fig. 2. No
Fig. 1 Patient flow. a For all patients who were lost to follow-up survival was assessed via local municipal population registries. b Written
informed consent and patient data were transferred to the study centre with a delay of more than 12 months; thus, follow-up measurement was
not possible within the scheduled follow-up period
Table 1 Characteristics of participating ICUs
ICUs N
Volume
Number of ventilated patients per year/100, Md (IQR) 48 4.93 (3.87–8.35)
Proportion of ventilated patients on all patients, Md (IQR) 47 0.44 (0.30–0.59)
Process quality
Daily multiprofessional ward rounds with documentation of daily therapy goals, N (%) 51 51 (100)
Weekly microbiological ward rounds, N (%) 52 37 (71.2)
Structural quality
Proportion of physicians with completed specialised training on all physicians, Md (IQR) 52 0.25 (0.16–0.33)
Direction with additional training “intensive medicine”, N (%) 52 51 (98.1)
General characteristics
Member of ARDS-network, N (%) 53 37 (69.8)
Level of care: University hospital, N (%) 53 28 (52.8)
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substantial increase in SF-12 values was observed be-
tween 3 and 12 months. Slightly over half of the pa-
tients returned to work after 1 year.
Analytical results
The main analysis refers to the effect of QoC on HRQoL
(Table 5, additional file 2) and RtW (Table 2) after
12 months, and additional analyses were computed for
three (Table 6, additional file 3) and 6 months (Table 7,
additional file 4) and mortality (Table 3).
Main analytical results
There was no significant association between most QoC
variables and HRQoL at 12 months (Table 5, additional file
2). However, in the fully adjusted analysis, treatment in
ICUs that had a higher percentage of ventilated patients
was significantly associated with a decreased PCS-12. The
analysis of the effects of QoC on RtW after 12 months
(Cox regression analyses, Table 2) showed a significantly
decreased hazard of RtW for patients treated in institutions
with a higher proportion of ventilated of patients but no
significant association was found for all further variables.
Additional analytical results
In the fully adjusted analysis of the three-month
follow-up (Table 6, additional file 3), a higher per-
centage of patients ventilated was significantly associ-
ated with a decreased PCS-12. There was a trend
towards a decreased PCS-12 for patients treated in
university hospitals (p = 0.054). No significant
Fig. 2 SF-12 values of survivors of ARDS after 12 months (a). Probability of not returning to work (b)
Table 2 Cox regression analyses of RtW on quality of care in 12 months respondents
12 months follow up: RtW unadjusted minimally adjusted a fully adjusted b
N Haz. Ratio (CI) p-value N Haz. Ratio (CI) p-value N Haz. Ratio (CI) p-value
Volume
N of ventilated patients per year/100 165 0.982 (0.941–1.024) 0.400 138 0.985 (0.940–1.032) 0.525 125 0.975 (0.924–1.029) 0.360
Proportion of ventilated patients on
all patients
159 0.366 (0.115–1.163) 0.088 135 0.350 (0.097–1.266) 0.110 122 0.182 (0.041–0.803) 0.024
Process quality
Weekly microbiological ward rounds 175 0.843 (0.485–1.466) 0.546 148 0.743 (0.378–1.459) 0.388 134 0.787 (0.338–1.831) 0.578
Structural quality
Proportion of physicians with
completed specialised training
on all physicians
175 2.674 (0.459–15.571) 0.274 148 1.230 (0.141–10.726) 0.852 134 4.829 (0.436–53.482) 0.199
General characteristics
Member of ARDS network 175 0.550 (0.311–0.972) 0.040 148 0.614 (0.341–1.106) 0.104 134 0.656 (0.312–1.381) 0.267
Level of Care: University hospital 175 0.829 (0.514–1.339) 0.444 148 0.845 (0.490–1.459) 0.545 134 0.724 (0.392–1.338) 0.303
a adjusted for age, sex, severity of ARDS; b adjusted for age, sex, severity of ARDS, SOFA score, SAPS-II score, diagnosis of ARDS (participating vs. other ICU),
education score
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associations were observed for any QoC parameter
and 6 months HRQoL (Table 7, additional file 4).
Based on a logistic regression analysis among ICU sur-
vivors twelve-month mortality risk (Table 3) was signifi-
cantly elevated for patients treated in institutions with a
higher number of ventilated patients per year. Addition-
ally, patients treated in university hospitals had a signifi-
cantly increased twelve-month mortality risk (OR 1.946,
p = 0.032) compared to non-university institutions. A
trend was seen for a reduced mortality risk in patients




The main finding of our study was that of all the quality in-
dicators investigated – taking important confounding fac-
tors into account – only the proportion of ventilated
patients on all patients showed a significant (negative) asso-
ciation with both twelve-months physical HRQoL (PCS-12)
and RtW. Secondary findings were a negative significant
association of the proportion of ventilated patients on all
patients and positive significant associations between the
number of ventilated patients per year and university
hospital level of care with post ICU mortality risk. No other
quality indicator was significantly associated with the
outcomes of interest. The DACAPO survivor cohort was
characterized by a reduced HRQoL compared to the
general population, with a greater impairment in the
physical component compared to the mental component.
50% of the surviving patients who were in employment
before ARDS had returned to work one year after trans-
ferred from the ICU.
Interpretation, in relation to literature
Our results need careful interpretation. A study by Ray-
mondos et al. [13] showed that the hospital mortality
risk of ARDS patients was considerably higher in pa-
tients who were treated in non-university hospitals com-
pared to university institutions. However, the present
study did not demonstrate a similar effect for HRQoL or
RtW 1 year after discharge. A systematic review [26]
demonstrated that critically ill patients generally benefit
from institutions with high volume regarding mortality
with more substantial effects in high risk patients, and
there was evidence that this relationship is in part medi-
ated by key hospital or ICU organizational factors. We
could not confirm this evidence.
It must be noted though that in contrast to mortality,
HRQoL is a complex construct containing individual as-
pects (multiple dimensions, often operationalized as so-
cial, somatic and psychological variables [27]. Our above
mentioned systematic review [12] demonstrated signifi-
cant associations with HRQoL after ARDS only for de-
terminants which were closely related to the scales of
the HRQoL instruments and which were measured at
the same time as HRQoL.
We were unable to consider variables pertaining to the
period after discharge although the post ICU period may
play an important role in terms of HRQoL. For instance, a
prospective one-year follow-up of 126 patients who re-
ceived prolonged mechanical ventilation by Unroe et al.
[28] showed that these experienced multiple ‘trajectories’
after their transfer from the ICU, resulting in frequent read-
missions or transitions to various healthcare institutions.
It might be argued that we did not find strong associa-
tions between our exposures of interest (i.e. parameters of
QoC) and the different outcomes because 1) the exposures
Table 3 Logistic regression analyses of mortality on quality of care in ICU survivors
12 months follow up unadjusted minimally adjusted a fully adjusted b
N Odds Ratio (CI) p-value N Odds Ratio (CI) p-value N Odds Ratio (CI) p-value
Volume
N of ventilated patients per year/100 767 1.044 (1.013–1.076) 0.005 660 1.053 (1.017–1.090) 0.004 544 1.048 (1.008–1.090) 0.018
Proportion of ventilated patients
on all patients
749 1.476 (0.583–3.737) 0.411 646 1.228 (0.435–3.463) 0.698 533 1.856 (0.558–6.178) 0.313
Process quality
Weekly microbiological ward rounds 811 1.386 (0.869–2.212) 0.171 702 1.483 (0.861–2.552) 0.155 575 1.579 (0.835–2.988) 0.160
Structural quality
Proportion of physicians with
completed specialised training
on all physicians
811 0.058 (0.009–0.390) 0.003 702 0.072 (0.009–0.604) 0.015 575 0.098 (0.009–1.019) 0.052
General characteristics
Member of ARDS network 814 1.141 (0.645–2.019) 0.651 705 1.269 (0.687–2.342) 0.447 577 1.632 (0.765–3.485) 0.205
Level of Care: University hospital 814 1.636 (1.029–2.602) 0.037 705 1.638 (0.981–2.736) 0.059 577 1.946 (1.059–3.576) 0.032
a adjusted for age, sex, severity of ARDS; b adjusted for age, sex, severity of ARDS, BMI, cause of ARDS, SAPS-II score, SOFA score, diagnosis of ARDS (participating
vs. other ICU), nationality
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showed little variability and 2) effects may have been seen if
intermediary outcomes such as length of ventilation or pre-
vention of multiorgan failure would have been considered.
However, when it became clear that the quality indicators
that were chosen initially did not show sufficient variability,
we considered further quality indicators which were related
to those that were chosen initially. These indicators did in-
deed show variability. Second, our research interest was
precisely to study modifiable institutional-level indicators of
quality of care in relation to patient-level outcomes. We are
coming from a public health/health care research perspec-
tive in which we can improve health or achieve better dis-
ease outcomes, even if we do not know the mechanisms
linking exposure to outcome. In light of this background,
we did not attempt to explore pathways between QIs,
HRQoL, RtW or mortality through intermediary outcomes.
Treatment-related exposures not assessed on the institu-
tional but on the individual patient level (parameters of the
intensity of acute care management and critical events)
have been investigated in a separate paper [29].
Strenghts and limitations
We were successful in the conduct of a prospective pa-
tient cohort study with regular follow-ups. Unfortu-
nately, the number of people lost to follow-up was
considerable which may have introduced attrition bias.
ICU mortality was not even used as outcome in second-
ary analysis because the recruitment strategies used fo-
cused on the survivor cohort as baseline. For instance,
only surviving patients or patients with a legal guardian
providing informed consent could be included at some
sites, while consent by next-of-kin was acceptable at
other sites. Any analysis of factors predictive of ICU
mortality would therefore be seriously biased.
Although we adjusted for ARDS severity in our min-
imally adjusted models, and further corrected for SAPS-
II and SOFA scores in the fully adjusted regression
models, residual confounding may still be present in re-
lation to ARDS severity/case-mix which might explain
our findings. Treatment received before or after ICU
care was also not corrected for which might have further
contributed to residual confounding.
Measuring QoC in the critical care setting is challen-
ging. In a review by Flaatten et al. [30] 63 quality indica-
tors (QI) measuring quality of structure, process and
outcome of care were identified, which are in use with a
large variation between countries and no single QI was
common for all. QIs for structure predominantly refer to
the qualification and quantity of health care professionals,
as well as the number of ventilated patients per year [31]
process quality indicators are more complex, numerous
and they refer to actual recommendations of guidelines
(ventilation strategies, nutrition, transfusion strategy etc.).
These indicators must be defined by experts or Delphi
rounds and they are difficult to be monitored continu-
ously in clinical practice. Usually QIs for outcome include
standardized mortality (ICU, hospital, 60- or 90-days) or
the incidence of decubiti [31]. No previous investigation
used QIs for an assessment of the association with
HRQoL. In our study we had to use established QIs only
assuming that they have value to describe sufficiently the
effect of care on patient-reported outcomes.
Future research
Further, in this paper, we only selected some QIs from
the full set. One idea for future research might be to use
the full set of QIs to develop a scoring system predictive
of patient-level outcome. Such an attempt however is
beyond the scope of this paper.
Given the importance of next of kin / family during
ICU stay [32], it would be interesting to additionally look
at patient-family satisfaction and patient-family engage-
ment in future research.
Conclusions
In conclusion, most indicators of acute QoC were not
significantly associated with one-year HRQoL or RtW in
ARDS survivors. Post-ICU exposure of ARDS survivors
may have attenuated the assumed effects of high-volume
care. Overall, we cannot rule out residual confounding
by case mix, treatment variables before or during ICU
stay and variables pertaining to the post ICU period.
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Additional file 1: Excel File. Table 4. Socio-demographic and general med-
ical characteristics of 12months respondents. a derived from educational and
professional level22, considered for regression analyses. SAPS-II score: Simplified
Acute Physiology Score II without Glasgow Coma Scale; SOFA score: Sequential
Organ Failure Assessment; BMI: Body Mass Index. bas assessed at admission at
the DACAPO ICU, c without consideration of Glasgow Coma Scale.
Additional file 2: Excel File. Table 5. Linear Regression Analyses of Health-
related Quality of Life after 12months on Quality of Care. a adjusted for age,
sex, severity of ARDS; b adjusted for age, sex, severity of ARDS, BMI, Educa-
tion score, SAPS-II score, SOFA score, diagnosis of ARDS (participating vs.
other ICU), self-reported physician-diagnosed mental disorder before ARDS
diagnosis; Notes: ARDS = acute respiratory distress syndrome; MCS-12 =
mental component scale of short-form 12 questionnaire; PCS-12 = physical
component scale of short-form 12 questionnaire.
Additional file 3: Excel File. Table 6. Linear Regression Analyses of
Health-related Quality of Life after 3 months on Quality of Care. a adjusted
for age, sex, severity of ARDS; b adjusted for age, sex, severity of ARDS,
BMI, Education score, SAPS-II score, SOFA score, diagnosis of ARDS (par-
ticipating vs. other ICU), self-reported physician-diagnosed mental dis-
order before ARDS diagnosis Notes: ARDS = acute respiratory distress
syndrome; MCS-12 =mental component scale of short-form 12 question-
naire; PCS-12 = physical component scale of short-form 12 questionnaire.
Additional file 4: Excel File. Table 7. Linear Regression Analyses of
Health-related Quality of Life after 6 months on Quality of Care. a adjusted
for age, sex, severity of ARDS; b adjusted for age, sex, severity of ARDS,
BMI, Education score, SAPS-II score, SOFA score, diagnosis of ARDS
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(participating vs. other ICU), self-reported physician-diagnosed mental dis-
order before ARDS diagnosis. Notes: ARDS = acute respiratory distress syn-
drome; MCS-12 =mental component scale of short-form 12
questionnaire; PCS-12 = physical component scale of short-form 12
questionnaire.
Abbreviations
ARDS: Acute respiratory distress syndrome; CRF: Case report form;
ICU: Intensive care Unit; IQR: Interquartile range; HRQoL: Health-related
quality of life; MCS-12: Mental component summary; Md: Median; PCS-
12: Physical component summary; PTSD: Post-traumatic stress disorder;
QoC: Quality of care; QoL: Quality of life; RtW: Return to work; SAPS-
II: Simplified acute physiology score II; SF-12: Short form 12 survey;
SOFA: Sequential organ failure assessment
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